THE ROLE OF PROBIOTICS IN THE EFFECTIVENESS OF TREATMENT
AGAINST HELICOBACTER PYLORI: RESULTS OF THE EUROPEAN REGISTRY
ONTHE MANAGEMENT OF HELICOBACTER PYLORI INFECTION (HP-EUREG)

a 2023

THE ROLE OF PROBIOTICS IN THE EFFECTIVENESS OF TREATMENT AGAINST HELICOBACTER PYLORI: RESULTS OF THE EUROPEAN REGISTRY ONTHE MANAGEMENT OF HELICOBACTER PYLORI INFECTION (HP-EUREG)

DEZA, Casas, J ALCEDO, M Lafuente BLASCO, J López LORENTE, Á PÉREZ-AÍSA et. al.

Basic information

Original name

THE ROLE OF PROBIOTICS IN THE EFFECTIVENESS OF TREATMENT AGAINST HELICOBACTER PYLORI: RESULTS OF THE EUROPEAN REGISTRY ONTHE MANAGEMENT OF HELICOBACTER PYLORI INFECTION (HP-EUREG)

Authors

DEZA, Casas, J ALCEDO, M Lafuente BLASCO, J López LORENTE, Á PÉREZ-AÍSA, M PAVONI, SALACINO, B TEPEŠ, JONAITIS, M Castro FERNÁNDEZ, M Pabón CARRASCO, A Keco HUERGA, I VOYNOVAN, L Bujanda FERNÁNDEZ DE PIÉROLA, A J LUCENDO, N Brglez JURECIC, M DENKOVSKI, P PHULL, Rodrigo SÁEZ, A LANAS, S J MARTÍNEZ-DOMÍNGUEZ, J M HUGUET, BORDIN, A GASBARRINI, J KUPCINSKA, G BABAYEVA, O GRIDNYEV, M LEJA, T ROKKAS, R Marcos PINTO, F LERANG, D BOLTIN, V PAPP, A TONKIC, S SMITH, H SIMSEK, M VENERITO, L BOYANOVA, V MILIVOJEVIC, Lumír KUNOVSKÝ, T MATYSIAK-BUDNIK, W MARLICZ, M DOULBERIS, A Cano CATALÀ, L Hernández VILLALBA, L Moreira RUIZ, O P NYSSEN, F MEGRAUD, MORAIN and J GISBERT

Edition

31st United European Gastroenterology Week 2023, 2023

Other information

Type of outcome

Konferenční abstrakt

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

URL

Impact factor

Impact factor: 6.000 in 2022

Organization unit

Faculty of Medicine

ISSN

Změněno: 18/12/2023 09:28, Mgr. Tereza Miškechová

Abstract

V originále

Introduction: There are doubts about the effectiveness of concomitant use of probiotics (PB) in the treatment of Helicobacter pylori infection. Objective: To determine whether the use of PB improves the effectiveness of eradication treatments used in Europe. Aims & Methods: Prospective, multicentre, non-interventional, prospective registry (Hp-EuReg) of the clinical practice of European gastroenterologists. Data were collected in an e-CRD in AEG-REDCap from 2013 to 2021. All data from countries with at least 30 cases undergoing eradication therapy and at least 1 with associated PB were included, using patients without PB as controls and grouping by geographical region. Modified intention-to-treat (mITT) analyses were performed, as well as multivariate analysis, assessing factors associated with treatment effectiveness.

Citovat

@proceedings{2351138,
   author = {Deza, Casas and Alcedo, J and Blasco, M Lafuente and Lorente, J López and PérezandAísa, Á and Pavoni, M and Salacino, and Tepeš, B and Jonaitis, and Fernández, M Castro and Carrasco, M Pabón and Huerga, A Keco and Voynovan, I and Fernández de Piérola, L Bujanda and Lucendo, A J and Jurecic, N Brglez and Denkovski, M and Phull, P and Sáez, Rodrigo and Lanas, A and MartínezandDomínguez, S J and Huguet, J M and Bordin, and Gasbarrini, A and Kupcinska, J and Babayeva, G and Gridnyev, O and Leja, M and Rokkas, T and Pinto, R Marcos and Lerang, F and Boltin, D and Papp, V and Tonkic, A and Smith, S and Simsek, H and Venerito, M and Boyanova, L and Milivojevic, V and Kunovský, Lumír and MatysiakandBudnik, T and Marlicz, W and Doulberis, M and Català, A Cano and Villalba, L Hernández and Ruiz, L Moreira and Nyssen, O P and Megraud, F and Morain, and Gisbert, J},
   booktitle = {31st United European Gastroenterology Week 2023},
   title = {THE ROLE OF PROBIOTICS IN THE EFFECTIVENESS OF TREATMENT AGAINST HELICOBACTER PYLORI: RESULTS OF THE EUROPEAN REGISTRY ONTHE MANAGEMENT OF HELICOBACTER PYLORI INFECTION (HP-EUREG)},
   url = {https://onlinelibrary.wiley.com/toc/20506414/2023/11/S8},
   year = {2023}
}

TY  - CONF
ID  - 2351138
AU  - Deza, Casas - Alcedo, J - Blasco, M Lafuente - Lorente, J López - Pérez-Aísa, Á - Pavoni, M - Salacino,
AU  - Tepeš, B - Jonaitis,
AU  - Fernández, M Castro - Carrasco, M Pabón - Huerga, A Keco - Voynovan, I - Fernández de Piérola, L Bujanda - Lucendo, A J - Jurecic, N Brglez - Denkovski, M - Phull, P - Sáez, Rodrigo - Lanas, A - Martínez-Domínguez, S J - Huguet, J M - Bordin,
AU  - Gasbarrini, A - Kupcinska, J - Babayeva, G - Gridnyev, O - Leja, M - Rokkas, T - Pinto, R Marcos - Lerang, F - Boltin, D - Papp, V - Tonkic, A - Smith, S - Simsek, H - Venerito, M - Boyanova, L - Milivojevic, V - Kunovský, Lumír - Matysiak-Budnik, T - Marlicz, W - Doulberis, M - Català, A Cano - Villalba, L Hernández - Ruiz, L Moreira - Nyssen, O P - Megraud, F - Morain,
AU  - Gisbert, J
PY  - 2023
TI  - THE ROLE OF PROBIOTICS IN THE EFFECTIVENESS OF TREATMENT AGAINST HELICOBACTER PYLORI: RESULTS OF THE EUROPEAN REGISTRY ONTHE MANAGEMENT OF HELICOBACTER PYLORI INFECTION (HP-EUREG)
UR  - https://onlinelibrary.wiley.com/toc/20506414/2023/11/S8
N2  - Introduction: There are doubts about the effectiveness of concomitant use of probiotics (PB) in the treatment of Helicobacter pylori infection. Objective: To determine whether the use of PB improves the effectiveness of eradication treatments used in Europe. Aims & Methods: Prospective, multicentre, non-interventional, prospective registry (Hp-EuReg) of the clinical practice of European gastroenterologists. Data were collected in an e-CRD in AEG-REDCap from 2013 to 2021. All data from countries with at least 30 cases undergoing eradication therapy and at least 1 with associated PB were included, using patients without PB as controls and grouping by geographical region. Modified intention-to-treat (mITT) analyses were performed, as well as multivariate analysis, assessing factors associated with treatment effectiveness.
ER  -

Detailed Information on Publication Record